Development and validation of a multiparametric MRI-based radiomics signature for distinguishing between indolent and aggressive prostate cancer

CONCLUSIONS: The multiparametric MRI-based radiomics signature can potentially serve as a noninvasive tool for distinguishing between indolent and aggressive PCa prior to therapy.ADVANCES IN KNOWLEDGE: The multiparametric MRI-based radiomics signature has the potential to noninvasively distinguish between the indolent and aggressive PCa, which might aid clinicians in making personalized therapeutic decisions.PMID:34289319 | DOI:10.1259/bjr.20210191

Source: The British Journal of Radiology - July 21, 2021 Category: Radiology Authors: Liuhui Zhang Donggen Jiang Chujie Chen Xiangwei Yang Hanqi Lei Zhuang Kang Hai Huang Jun Pang Source Type: research